4
Changes in Ownership
Eloxx Pharmaceuticals, Inc. Filed Acc 0001144204-13-050892
Options or other derivatives
- Chief Scientific Officer acquired 985,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
THOMPSON JOHN PHD · Chief Scientific Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2013-09-13 | Grant or award : show line 1 in the form Common Stock Option | +985,000 | $0.05 | 2023-09-13 | 985,000 | 2,203,276 | D |
Loading xslF345X03/form462246_20130916115145-.xml…